Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

L&S Research

This article was originally published in The Tan Sheet

Executive Summary

Discontinues advertising for its Cybergenics Cybertrim and Cybergenics Quick Trim products, according to a case report from the National Advertising Division of the Council for Better Business Bureaus. After NAD requested substantiation for weight loss claims and product endorsements made for the Cybergenics products, L&S Research said it discontinued the ads in question and is "undertaking a complete review of all of its advertising, promotional materials and labeling" and will be revising those materials. The company recently received a warning letter from FDA that cited some Cybergenics products as unapproved new drugs based on weight control claims ("The Tan Sheet" Feb. 21, In Brief)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS082656

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel